Click here - to use the wp menu builder

HomeTagsHER2DX

HER2DX

Features

Decade-Long Triumph: Paclitaxel and Trastuzumab in Small HER2-Positive Breast Cancer

BCNewswire Staff - February 13, 2024

Over a notable duration of nearly 11 years, a study just published in The Lancet, confirms that the combination therapy of adjuvant paclitaxel and...

Hot Topics

Outsmarting the Body’s Defenses: Unveiling Breast Cancer’s Escape Tactics

Promising Antibody Therapy Targets Only Cancer Cells in HER2-Positive Breast Cancer

Annual Breast Cancer Screening from Age 40 Proves Most Effective, CISNET Study Finds